Constitutive activation of PKA catalytic subunit in adrenal Cushing’s syndrome
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Corticotropin-independent Cushing's syndrome is caused by tumors or hyperplasia of the adrenal cortex. The molecular pathogenesis of cortisol-producing adrenal adenomas is not well understood. METHODS: We performed exome sequencing of tumor-tissue specimens from 10 patients with cortisol-producing adrenal adenomas and evaluated recurrent mutations in candidate genes in an additional 171 patients with adrenocortical tumors. We also performed genomewide copy-number analysis in 35 patients with cortisol-secreting bilateral adrenal hyperplasias. We studied the effects of these genetic defects both clinically and in vitro. RESULTS: Exome sequencing revealed somatic mutations in PRKACA, which encodes the catalytic subunit of cyclic AMP-dependent protein kinase (protein kinase A [PKA]), in 8 of 10 adenomas (c.617A→C in 7 and c.595_596insCAC in 1). Overall, PRKACA somatic mutations were identified in 22 of 59 unilateral adenomas (37%) from patients with overt Cushing's syndrome; these mutations were not detectable in 40 patients with subclinical hypercortisolism or in 82 patients with other adrenal tumors. Among 35 patients with cortisol-producing hyperplasias, 5 (including 2 first-degree relatives) carried a germline copy-number gain (duplication) of the genomic region on chromosome 19 that includes PRKACA. In vitro studies showed impaired inhibition of both PKA catalytic subunit mutants by the PKA regulatory subunit, whereas cells from patients with germline chromosomal gains showed increased protein levels of the PKA catalytic subunit; in both instances, basal PKA activity was increased. CONCLUSIONS: Genetic alterations of the catalytic subunit of PKA were found to be associated with human disease. Germline duplications of this gene resulted in bilateral adrenal hyperplasias, whereas somatic PRKACA mutations resulted in unilateral cortisol-producing adrenal adenomas. (Funded by the European Commission Seventh Framework Program and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Somatic activating mutations of protein kinase A catalytic subunit (PRKACA) has been implicated in up to 50% of patients with adenomas with clinical Cushing’s syndrome, but not in adenomas producing less cortisol (138,142,147).”
From Adrenal incidentaloma (2020) · cites this paper as [147]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Among these mutations, the most frequently found (PKA-CL205R) is a point mutation leading to substitution of Leu at position 205 (or 206, depending on the convention used for numbering) with Arg and has been found in up to 67% of Cushing’s syndrome patients (3–7).”
From Cushing’s syndrome driver mutation disrupts protein kinase A allosteric network, altering both regulation and substrate specificity (2019) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The L205R mutation was discovered independently in our laboratory and in other laboratories as the dominant genetic alteration in cortisol-producing adrenocortical adenomas responsible for Cushing’s syndrome (3–7).”
From Cushing’s syndrome driver mutation disrupts protein kinase A allosteric network, altering both regulation and substrate specificity (2019) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Later on, our group and others discovered single mutations or insertions at the R/C interface that are linked to adrenal Cushing’s syndrome (3–7).”
From Cushing’s syndrome driver mutation disrupts protein kinase A allosteric network, altering both regulation and substrate specificity (2019) · cites this paper as [6]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“As expected, the 60-minute post-ACTH cortisol was higher than the 30-minute cortisol on each of the cortisol assays evaluated [26, 28, 38].”
From New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays (2021) · cites this paper as [38]
Experimental — accuracy not yet measured
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Self-citationNewell-Price, J., Bertagna, X., Grossman, A. B., & Nieman, L. K. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68699-6 · Cited by 1,165
Kirschner, L. S., Carney, J. A., Pack, S. D., Taymans, S. E., Giatzakis, C., Cho, Y. S., Cho-Chung, Y. S., & Stratakis, C. A. (2000) · Nature Genetics · doi:10.1038/79238 · Cited by 1,153
Self-citationManagement of the clinically inapparent adrenal mass ("incidentaloma")
Grumbach, M. M., Biller, B. M. K., Braunstein, G. D., Campbell, K. K., Carney, J. A., Godley, P. A., Harris, E. L., Lee, J. K. T., Oertel, Y. C., Posner, M. C., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-5-200303040-00013 · Cited by 945 · cited 1×
“Adrenal adenomas are common, with a prevalence of at least 3% among persons older than 50 years of age.(3) Whereas only a subset of these tumors is associated with overt Cushing’s syndrome, some degree of cortisol excess is present, depending on the diagnostic criteria applied,(4) in up to 47% of patients with adrenal…”
BackgroundThe clinically inapparent adrenal mass: update in diagnosis and management
Mansmann, G., Lau, J., Balk, E., Rothberg, M., Miyachi, Y., & Bornstein, S. R. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0031 · Cited by 781
Incidence and Late Prognosis of Cushing’s Syndrome: A Population-Based Study1
Lindholm, J., Juul, S., Jørgensen, J. O. L., Astrup, J., Bjerre, P., Feldt-Rasmussen, U., Hagen, C., Jørgensen, J., Kosteljanetz, M., Kristensen, L. Ø., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7093 · Cited by 619
Beuschlein, F., Boulkroun, S., Osswald, A., Wieland, T., Nielsen, H. N., Lichtenauer, U. D., Penton, D., Schack, V. R., Amar, L., Fischer, E., et al. (2013) · Nature Genetics · doi:10.1038/ng.2550 · Cited by 577
Self-citationPersistent cAMP-Signals Triggered by Internalized G-Protein–Coupled Receptors
Calebiro, D., Nikolaev, V. O., Gagliani, M. C., de Filippis, T., Dees, C., Tacchetti, C., Persani, L., & Lohse, M. J. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000172 · Cited by 574
Self-citationIncidence and Late Prognosis of Cushing's Syndrome: A Population-Based Study
Lindholm, J. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.1.117 · Cited by 507
Assembly of allosteric macromolecular switches: lessons from PKA
Taylor, S. S., Ilouz, R., Zhang, P., & Kornev, A. P. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3432 · Cited by 477
Gastric Inhibitory Polypeptide–Dependent Cortisol Hypersecretion — A New Cause of Cushing's Syndrome
Lacroix, A., Bolté, E., Tremblay, J., Dupré, J., Poitras, P., Fournier, H., Garon, J., Garrel, D., Bayard, F., Taillefer, R., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210013271402 · Cited by 360
Horvath, A., Boikos, S., Giatzakis, C., Robinson-White, A., Groussin, L., Griffin, K. J., Stein, E., Levine, E., Delimpasi, G., Hsiao, H. P., et al. (2006) · Nature Genetics · doi:10.1038/ng1809 · Cited by 352
Self-citationBertherat, J. Y., Groussin, L., Sandrini, F., Matyakhina, L., Bei, T. A., Stergiopoulos, S. G., Papageorgiou, T., Bourdeau, I., Kirschner, L. S., Vincent-Dejean, C., et al. (2003) · PubMed · Cited by 276
Self-citationLeuprolide acetate therapy in luteinizing hormone-dependent Cushing's syndrome.
Lacroix, A., Hamet, P., & Boutin, J.-M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911183412104 · Cited by 244
Bonaglia, M. C., Giorda, R., Beri, S., De Agostini, C., Novara, F., Fichera, M., Grillo, L., Galesi, O., Vetro, A., Ciccone, R., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002173 · Cited by 224 · cited 1×
“Array-based comparative genomic hybridization analysis was performed with the use of commercial arrays (Agilent Technologies), according to the manufacturer’s instructions and as described previously.(22) Technical details are provided in the Supplementary Appendix.”
MethodSelf-citationFragoso, M. C. B. V., Domenice, S., Latronico, A. C., Martin, R. M., Pereira, M. A. A., Zerbini, M. C. N., Lucon, A. M., & Mendonca, B. B. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021362 · Cited by 190
Mutation in PDE8B,a Cyclic AMP–Specific Phosphodiesterase in Adrenal Hyperplasia
Horvath, A., Mericq, V., & Stratakis, C. A. (2008) · New England Journal of Medicine · doi:10.1056/nejmc0706182 · Cited by 190
Self-citationHsiao, H.-P., Kirschner, L. S., Bourdeau, I., Keil, M. F., Boikos, S. A., Verma, S., Robinson-White, A. J., Nesterova, M., Lacroix, A., & Stratakis, C. A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0516 · Cited by 183
Self-citationHorvath, A., Bertherat, J., Groussin, L., Guillaud-Bataille, M., Tsang, K., Cazabat, L., Libé, R., Remmers, E., René-Corail, F., Faucz, F. R., et al. (2010) · Human Mutation · doi:10.1002/humu.21178 · Cited by 175
Self-citationKirschner, L. S., Kusewitt, D. F., Matyakhina, L., Towns, W. H., Carney, J. A., Westphal, H., & Stratakis, C. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0580 · Cited by 175
Self-citationManagement of the Clinically Inapparent Adrenal Mass
Braunstein, G. D., & Panel, F. T. N. I. O. H. S.-O.-T. S. A. I. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-5-200403020-00019 · Cited by 172
Structure and Allostery of the PKA RIIβ Tetrameric Holoenzyme
Zhang, P., Smith-Nguyen, E. V., Keshwani, M. M., Deal, M. S., Kornev, A. P., & Taylor, S. S. (2012) · Science · doi:10.1126/science.1213979 · Cited by 171
Aberrant G‐protein coupled receptor expression in relation to adrenocortical overfunction
Lacroix, A., Bourdeau, I., Lampron, A., Mazzuco, T. L., Tremblay, J., & Hamet, P. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03689.x · Cited by 150
Bonnet, S., Gaujoux, S., Launay, P., Baudry, C., Chokri, I., Ragazzon, B., Libé, R., René-Corail, F., Audebourg, A., Vacher-Lavenu, M.-C., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1885 · Cited by 133
Self-citationOrellana, S. A., & McKnight, G. S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4726 · Cited by 131
Subclinical Cushing’s syndrome: definition and management
Terzolo, M., Pia, A., & Reimondo, G. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04253.x · Cited by 130
cAMP activation of PKA defines an ancient signaling mechanism
Das, R., Esposito, V., Abu-Abed, M., Anand, G. S., Taylor, S. S., & Melacini, G. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609033103 · Cited by 130 · cited 4×
“org march 13, 2014 1027 kinase and provides a clear example of allosteric regulation.(35) In its inactive state, it is a tetrameric holoenzyme consisting of a dimer of two regulatory and two catalytic subunits; under physiologic conditions, PKA activity is induced by G-protein–coupled receptors through increased level…”
BackgroundInfluentialPrimary Bimorphic Adrenocortical Disease: Cause of Hypercortisolism in McCune-Albright Syndrome
Carney, J. A., Young, W. F., & Stratakis, C. A. (2011) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31821ec4ce · Cited by 98
Self-citationLouiset, E., Stratakis, C. A., Perraudin, V., Griffin, K. J., Libé, R., Cabrol, S., Fève, B., Young, J., Groussin, L., Bertherat, J., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0031 · Cited by 88
Self-citationRonchi, C. L., Sbiera, S., Leich, E., Henzel, K., Rosenwald, A., Allolio, B., & Fassnacht, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073959 · Cited by 68
Self-citationProtein Kinase A Effects of an Expressed PRKAR1A Mutation Associated with Aggressive Tumors
Meoli, E., Bossis, I., Cazabat, L., Mavrakis, M., Horvath, A., Stergiopoulos, S., Shiferaw, M. L., Fumey, G., Perlemoine, K., Muchow, M., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0064 · Cited by 61
Self-citationStratakis, C. A. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.01.015 · Cited by 44
Self-citationWilmot Roussel, H., Vezzosi, D., Rizk-Rabin, M., Barreau, O., Ragazzon, B., René-Corail, F., de Reynies, A., Bertherat, J., & Assié, G. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4237 · Cited by 43
Self-citationBimpaki, E. I., Nesterova, M., & Stratakis, C. A. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0027 · Cited by 41
Self-citationRonchi, C. L., Leich, E., Sbiera, S., Weismann, D., Rosenwald, A., Allolio, B., & Fassnacht, M. (2012) · Neoplasia · doi:10.1593/neo.111758 · Cited by 40
Self-citationCalebiro, D., de Filippis, T., Lucchi, S., Martinez, F., Porazzi, P., Trivellato, R., Locati, M., Beck-Peccoz, P., & Persani, L. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0493 · Cited by 38
Self-citationHerbst, K. J., Allen, M. D., & Zhang, J. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05459-11 · Cited by 34
Kobayashi, H., Usui, T., Fukata, J., Yoshimasa, T., Oki, Y., & Nakao, K. (2000) · Endocrine Journal · doi:10.1507/endocrj.47.461 · Cited by 31
Vincent-Dejean, C., Cazabat, L., Groussin, L., Perlemoine, K., Fumey, G., Tissier, F., BERTAGNA, X. Y., & Bertherat, J. Y. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0819 · Cited by 29
Self-citationDrosophila Costal1 Mutations Are Alleles of Protein Kinase A That Modulate Hedgehog Signaling
Collier, L. S., Suyama, K. L., Anderson, J. H., & Scott, M. P. (2004) · Genetics · doi:10.1534/genetics.103.024992 · Cited by 17
Research works printed but not linked: 1
- Bertherat J, 2003, Cancer Res, 63, 5308
Cited by
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Self-citationGenomic spectra of biliary tract cancer
Nakamura, H., Arai, Y., Totoki, Y., Shirota, T., Elzawahry, A., Kato, M., Hama, N., Hosoda, F., Urushidate, T., Ohashi, S., et al. (2015) · Nature Genetics · doi:10.1038/ng.3375 · Cited by 1,284
Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma
Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., Lerario, A. M., Else, T., Knijnenburg, T. A., Ciriello, G., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.04.002 · Cited by 657
“The high frequency of PRKAR1A mutations expands the role of PKA signaling in ACC and is consistent with PRKACA somatic mutations being the founder lesion of benign adrenal tumor associated with endocrinopathies such as Cushing syndrome (Beuschlein et al., 2014).”
InfluentialSelf-citationMutations in the deubiquitinase gene USP8 cause Cushing's disease
Reincke, M., Sbiera, S., Hayakawa, A., Theodoropoulou, M., Osswald, A., Beuschlein, F., Meitinger, T., Mizuno-Yamasaki, E., Kawaguchi, K., Saeki, Y., et al. (2015) · Nature Genetics · doi:10.1038/ng.3166 · Cited by 599
Self-citationCorrea, R., Salpea, P., & Stratakis, C. A. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0209 · Cited by 378
Self-citation
Metadata
- Authors
- Beuschlein, F., Fassnacht, M., Assié, G., Calebiro, D., Stratakis, C. A., Osswald, A., Ronchi, C. L., Wieland, T., Sbiera, S., Faucz, F. R., Schaak, K., Schmittfull, A., Schwarzmayr, T., Barreau, O., Vezzosi, D., Rizk-Rabin, M., Zabel, U., Szarek, E., Salpea, P., Forlino, A., Vetro, A., Zuffardi, O., Kisker, C., Diener, S., Meitinger, T., Lohse, M. J., Reincke, M., Bertherat, J., Strom, T. M., & Allolio, B.
- Affiliations
- University of Würzburg (DE)
- Centre National de la Recherche Scientifique (FR)
- National Institutes of Health (US)
- Helmholtz Munich (DE)
- University of Pavia (IT)
- Policlinico San Matteo Fondazione (IT)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2014-03-13
- Volume
- 370
- Issue
- 11
- Pages
- 1019-1028
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC4727447
- OpenAlex
- W2040816499
- Cited by
- 443
- References
- 40
- Citations by year
- 2026: 19 · 2025: 23 · 2024: 28 · 2023: 26 · 2022: 39 · 2021: 40 · 2020: 28 · 2019: 25 · 2018: 34 · 2017: 38 · 2016: 51 · 2015: 50 · 2014: 38
- FWCI
- 58.42
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion, other-oa)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Site cant be reached (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Funders
- George Washington University
- Johns Hopkins University
- Cedars-Sinai Medical Center
- Quest Diagnostics
- Otsuka America
- European Commission (259735)
- National Institutes of Health
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (ZIAHD008920)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- Cushing's syndrome, adrenal hyperplasia, PRKACA, protein kinase A catalytic subunit, somatic mutations, adrenocortical tumors, hypercortisolism
- MeSH terms
- Adenoma, Adrenal Gland Neoplasms, Adrenal Hyperplasia, Congenital, Adult, Cushing Syndrome, Humans, Hydrocortisone, Middle Aged, Mutation, Protein Conformation, Sequence Analysis, DNA, Cyclic AMP-Dependent Protein Kinases, Germ-Line Mutation, Catalytic Domain, Exome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.